Welcome Ben Johnson to the MAI team! Ben has 10 years of experience accelerating scientific discovery through commercializing life science research products and is leading our Key Customer Program for #FES#DNAsynthesis.
#JoinUs: https://t.co/9VnzCw7c5B
#TheFutureIsInOurDNA
Our new CEO spoke about the exciting potential of our #tRNA bioplatform to address unmet medical needs for #rarediseases.
Watch 3 Questions with @FlagshipPioneer to learn more about Michelle's commitment to patients and advancing #tRNAtherapeutics.
Are you looking to apply the full potential of your experience and education? At Alltrna, we are not only committed to unlocking the vast therapeutic potential of #tRNA but also the full potential of our team.
#JoinUs: https://t.co/XObaWZtk16
#biotech#boston#jobs#careers
Going to #BuiltWithBiology and interested in #DNA synthesis?
Join us with @CodexisInc to hear more about co-developing our evolved DNA polymerase, what makes #DNAsynthesis “Fully Enzymatic,” and how to get early access to our #FES technology.
#synbio#synbio101@BuiltWithBio
Today we welcome world leaders in #RNA research and therapeutics to our SAB. We will work with them to harness the power of #tRNA biology to advance a single medicine with the potential to treat thousands of diseases.
Release: https://t.co/rd2XfXMGMD
https://t.co/kMConnQy7w
#Phoenix is hot and so is the science. At the heart of #DTPHX, scientific innovation is heating up at @Biomed_PHX. We're proud to be part of this community that supports our development of #cancer-fighting therapies.
https://t.co/yx9RzX1qUU
#AZ#biotech@downtownphoenix@ASU
We just posted a #job opening for Sr. #Scientist, Molecular and Cellular #Biology#Research. We are dedicated to helping find new therapeutic options for patients with #rarediseaes. Come work with us!
Learn more at: https://t.co/ctmlv7pfyW
#biotech#careers
#WorldCancerDay is today, and we are helping to raise awareness of some common #cancer signs and symptoms. While symptoms may vary, early detection can be helpful in #cancerprevention.
Learn more at: https://t.co/kqOA6ZlEx2
For those who have heard me talk about the three "D's" in #biotech#PR, there are also three "D's" in #geneticmedicines: Delivery, Delivery, Delivery.
It's been great to work with the team at GenEdit to support this collaboration announcement with Sarepta.
We're excited to announce our collaboration with @Sarepta to develop new #geneticmedicines for neuromuscular diseases and the progress we have made together in using our #NanoGalaxy platform to target muscle for #geneediting.
Read more: https://t.co/ZqbHDQ9eLH